MedTrace Logo

Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously

NCT01543672 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2019-06-27

No results posted yet for this study

Summary

Treatment of larger tumor volumes or ≥ 2 lung metastases simultaneously in lung cancer patient using Stereotactic Body Radiation Therapy (SBRT) in a mean-lung dose escalation study.

Conditions

Interventions

RADIATION

Stereotactic Body Radiotherapy (SBRT)

3-5 fractions within 10-14 days

RADIATION

Stereotactic Body Radiotherapy (SBRT)

3-5 fractions per tumor within one treatment session or sequential within one month

Sponsors & Collaborators

  • The Netherlands Cancer Institute

    lead OTHER

Principal Investigators

  • Heike Peulen, MD · The Netherlands Cancer Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-22
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United States
  • Canada
  • Germany
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01543672 on ClinicalTrials.gov